Health
COVID-19 survivors urged to donate blood for trials – The Australian Financial Review
Men recovering from COVID-19 are being urgently sought to donate their antibodies for two treatment trials to help acute hospitalised patients.
The other, REMAP-CAP, focuses on critically ill COVID-19 patients who require intensive care. Convalescent plasma is being used with antiviral medications, immune function modulators, anti-coagulation therapy to assess the impact on acute patients.
Anyone who has had COVID-19 but has been free of it for 28 days is eligible to donate. “We would encourage people to come forward,” Dr Daly said.
Men who are recovering from COVID-19 are being sought in particular, because research suggests they hav…
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General13 hours ago‘I can’t start at zero now’: Aussies call for clarity after super cyber attack